- TRADE NAME: Valcyte (Roche)
- INDICATIONS: Cytomegalovirus retinitis (CMV) in patients with AIDS, prevention of CMV disease in high-risk transplant patients
- CLASS: Antiviral, Guanine nucleoside analog
- HALF-LIFE: 4 hours (in severe renal impairment up to 68%)
- See adverse reactions attributed to class:
Antiviral
Valganciclovir is rapidly converted to ganciclovir in the body.
HEMATOLOGIC TOXICITY, IMPAIRMENT OF FERTILITY, FETAL TOXICITY, MUTAGENESIS AND CARCINOGENESIS
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023